(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 5.66% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Zimmer Biomet Holdings's revenue in 2025 is $7,833,800,000.On average, 29 Wall Street analysts forecast ZBH's revenue for 2025 to be $1,645,583,339,088, with the lowest ZBH revenue forecast at $1,590,908,847,504, and the highest ZBH revenue forecast at $1,719,869,333,088. On average, 29 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,742,848,467,232, with the lowest ZBH revenue forecast at $1,661,034,825,840, and the highest ZBH revenue forecast at $1,854,970,794,176.
In 2027, ZBH is forecast to generate $1,827,435,452,400 in revenue, with the lowest revenue forecast at $1,728,189,364,416 and the highest revenue forecast at $1,951,245,442,400.